admin
I'm here for our amazing Cancer Warriors!

Preview

Prognostic Marker in Operable Breast Cancer #SABCS19
Prognostic Marker in Operable Breast Cancer #SABCS19
The FLEX Real World Data #SABCS19 @BaptistHealthSA
The FLEX Real World Data #SABCS19 @BaptistHealthSA
Agendia Presents New Data at #SABCS19 in Breast Cancer
Agendia Presents New Data at #SABCS19 in Breast Cancer
Phase III KEYNOTE-522 Trial KEYTRUDA #SABCS
Phase III KEYNOTE-522 Trial KEYTRUDA #SABCS
Kidney Cancer Experts at UT Southwestern discuss the CARMENA trial
Kidney Cancer Experts at UT Southwestern discuss the CARMENA trial
superboy

Preview

Targeting RCC Metabolism: Glutaminase Inhibition
Targeting RCC Metabolism: Glutaminase Inhibition
TIL products from Renal Cell Carcinomas are tumor-specific but poor cytokine producers
TIL products from Renal Cell Carcinomas are tumor-specific but poor cytokine producers
NEW TARGETS IN RCC
NEW TARGETS IN RCC
Novel epigenetic targeting approaches
Novel epigenetic targeting approaches
HIF-2aa new target in metastatic RCC
HIF-2a a new target in metastatic RCC
Randomised phase 2 study of sapanisertib (TAK?228/MLN0128) ± TAK-117 versus everolimus in patients with VEGF-targeted therapy-refractory metastatic clear cell renal cell carcinoma
Randomised phase 2 study of sapanisertib (TAK?228/MLN0128) ± TAK-117 versus everolimus in patients with VEGF-targeted therapy-refractory metastatic clear cell renal cell carcinoma
imedex

Preview

Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management
Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management
CAR-T: Management of Cytokine Release Syndrome and Neurotoxicity
CAR-T: Management of Cytokine Release Syndrome and Neurotoxicity
Update: Relapsed/Refractory Follicular Lymphoma
Update: Relapsed/Refractory Follicular Lymphoma
Follicular Lymphoma: Update on Upfront and Maintenance Therapy
Follicular Lymphoma: Update on Upfront and Maintenance Therapy
CAR-T in Lymphoma
CAR-T in Lymphoma
Peripheral T-Cell Lymphoma: What is New on the Horizon?
Peripheral T-Cell Lymphoma: What is New on the Horizon?
patientpower

Preview

giuspeppe curigliano ITALIAN video 1
giuspeppe curigliano ITALIAN video 1
giuspeppe curigliano ITALIAN video 3
giuspeppe curigliano ITALIAN video 3
giuspeppe curigliano ITALIAN video 4
giuspeppe curigliano ITALIAN video 4
giuspeppe curigliano ITALIAN video 2
giuspeppe curigliano ITALIAN video 2
colombo ITALIÀ video 1-
colombo ITALIÀ video 1-
colombo ITALIÀ video 2
colombo ITALIÀ video 2

Preview

Introduction & Individualizing Treatment for Your Patients with RRMM: Selecting Among the Available Options
Introduction & Individualizing Treatment for Your Patients with RRMM: Selecting Among the Available Options
Optimal Strategies for the Identification and Management of Treatment-Related Adverse Events
Optimal Strategies for the Identification and Management of Treatment-Related Adverse Events
Improving Practice and Future Perspectives: Panel Discussion
Improving Practice and Future Perspectives: Panel Discussion
gistonline

Preview

Domande e discussione col pubblico a seguito della presentazione “Gestione degli effetti collaterali delle terapie e delle complicanze post-chirurgiche”
Domande e discussione col pubblico a seguito della presentazione “Gestione degli effetti collaterali delle terapie e delle complicanze post-chirurgiche”
Prof. Loris Pironi, Direttore Centro di Riferimento Regionale per l'Insufficienza Intestinale Cronica Benigna, Policlinico S. Orsola-Malpighi, Università di Bologna
Prof. Loris Pironi, Direttore Centro di Riferimento Regionale per l'Insufficienza Intestinale Cronica Benigna, Policlinico S. Orsola-Malpighi, Università di Bologna
Dott. Paolo G. Casali, Responsabile SSD Oncologia Medica Tumori Mesenchimali dell'Adulto, Fondazione IRCCS Istituto Nazionale Tumori – Milano
Dott. Paolo G. Casali, Responsabile SSD Oncologia Medica Tumori Mesenchimali dell'Adulto, Fondazione IRCCS Istituto Nazionale Tumori – Milano
Dott.ssa Maria A. Pantaleo, SSD Oncologia Medica-Biasco, AO Universitaria Policlinico Sant'Orsola Malpighi, Università di Bologna
Dott.ssa Maria A. Pantaleo, SSD Oncologia Medica-Biasco, AO Universitaria Policlinico Sant'Orsola Malpighi, Università di Bologna
Domande e discussione con il pubblico a seguito della presentazione &quotTerapia con Regorafenib in terza linea di trattamento"
Domande e discussione con il pubblico a seguito della presentazione "Terapia con Regorafenib in terza linea di trattamento"
Dott.ssa Elena Fumagalli, SSD Oncologia Medica Tumori Mesenchimali dell'Adulto, Fondazione IRCCS Istituto Nazionale Tumori - Milano
Dott.ssa Elena Fumagalli, SSD Oncologia Medica Tumori Mesenchimali dell'Adulto, Fondazione IRCCS Istituto Nazionale Tumori - Milano
roswellpark

Preview

Back Pain and Cancer
Back Pain and Cancer
Indications for Kyphoplasty and Vertebroplasty
Indications for Kyphoplasty and Vertebroplasty
Next-Generation Sequencing for Oncologists
Next-Generation Sequencing for Oncologists
How to Choose Your Cancer Surgeon
How to Choose Your Cancer Surgeon
Fundamentals of Cancer Immunotherapy
Fundamentals of Cancer Immunotherapy
Unique Clinical Trial Involves New Adoptive T Cell Therapy
Unique Clinical Trial Involves New Adoptive T Cell Therapy
vhsimons

Preview

Dr. Tewari Racial Disparities in Pca
Dr. Tewari Racial Disparities in Pca
African-American Prostate Cancer
African-American Prostate Cancer
Active Surveillance in High Risk populations
Active Surveillance in High Risk populations
The new Mo stage for Prostate Cancer progression
The new Mo stage for Prostate Cancer progression
PARP Inhibitors and Prostate Cancer
PARP Inhibitors and Prostate Cancer
Immunotherapy and Prostate Cancer
Immunotherapy and Prostate Cancer
kidneycancer

Preview

Role of Radiation in Kidney Cancer
Role of Radiation in Kidney Cancer
Treatment-Free Survival, With and Without Toxicity
Treatment-Free Survival, With and Without Toxicity
Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1
Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1
What's To Come in Modern Imaging Technology
What's To Come in Modern Imaging Technology
Modern Imaging Technology
Modern Imaging Technology
Management of Clinical Cases in Kidney Cancer
Management of Clinical Cases in Kidney Cancer
oncozine

Preview

Pediatric Oncology | Childhood Cancer
Pediatric Oncology | Childhood Cancer
Breast Cancer facts
Breast Cancer facts
Early-stage Breast Cancer and Patients' Risk of Disease Recurrence
Early-stage Breast Cancer and Patients' Risk of Disease Recurrence
African-American Women and Breast Cancer Risk
African-American Women and Breast Cancer Risk
Gene Called USP9X and Tamoxifen Resistance
Gene Called USP9X and Tamoxifen Resistance
Molecular Subtyping Improves Breast Cancer Treatment
Molecular Subtyping Improves Breast Cancer Treatment